CLA and BR drafted the manuscript
CLA and BR drafted the manuscript. immunoblotting using the indicated antibodies. The constructs include a C-terminal hemagglutinin (HA)-label bcr3601-S5.docx (227K) GUID:?77234FDB-42CB-4F99-A017-6AA7FB28572F Extra file 6: Body S2 Phosphoinositide 3-kinase (PI3K) mutation shifts the half-maximal inhibitory concentration for lapatinib inhibition of PI3K signaling. Cells expressing wild-type or mutant PI3K constructs had been treated with a variety of […]
Recent Comments